SLC6A2 gene
Evidence from:
primary |
all sources
Related entities (3)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| cocaine | regulates | SLC6A2 | — | 1 |
| SLC6A2 | associated_with | ADHD | 0.001 | 1 |
| SLC6A2 | risk_factor_for | HPA axis dysregulation | — | 1 |
Mentioned in (10)
Papers in which this entity is mentioned.
- Effects of chronic intermittent ethanol exposure and withdrawal on neuroblastoma cell transcriptome. (2020)
- The Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming. (2016)
- Tissue-Specific Gene Repositioning by Muscle Nuclear Membrane Proteins Enhances Repression of Critical Developmental Genes during Myogenesis. (2016)
- Dissecting impulsivity and its relationships to drug addictions. (2014)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
- Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. (2012)
- Fetal effects of psychoactive drugs. (2009)
- Genome-wide association studies in ADHD. (2009)
- Neuroimaging of children following prenatal drug exposure. (2009)
- Neuroimaging of children following prenatal drug exposure. (2009)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| slc6a2 | gene | 9 | 17 |
| net | gene | 2 | 2 |
| norepinephrine transporter | gene | 1 | 1 |